The study was conducted by Dr. Rimonta Febby Gunanegara from Maranatha Christian University, Bandung, together with Dr. Hanom Husni Syam from Padjadjaran University and Dr. Hasan Sadikin General Hospital, Bandung. Their research was published in 2026 in the International Journal of Applied and Scientific Research (IJASR).
The findings arrive at a crucial time, as infertility remains a major global health challenge. According to the World Health Organization (WHO), approximately one in six people worldwide experiences infertility during their reproductive years. Beyond its medical implications, infertility also affects mental health, family relationships, and socioeconomic well-being.
Conventional fertility treatments primarily focus on achieving conception. However, many women experience underlying biological conditions such as diminished ovarian reserve, premature ovarian insufficiency, endometrial disorders, hormonal imbalances, and age-related reproductive decline. These complex conditions have driven researchers to explore therapies that not only assist pregnancy but also restore reproductive function.
Combining Two Cutting-Edge Medical Technologies
The review highlights two rapidly advancing fields in reproductive medicine.
The first is stem cell therapy, a regenerative treatment that uses stem cells capable of repairing and regenerating damaged tissues. In female infertility, stem cells may restore ovarian function, repair the uterine lining, and promote regeneration of reproductive tissues.
The second is precision reproductive medicine, an individualized treatment strategy that tailors fertility care according to each patient's unique biological profile. Physicians use genetic information, hormonal biomarkers, reproductive history, clinical characteristics, and environmental factors to design personalized treatment plans.
According to the authors, integrating these two approaches could enable clinicians to repair reproductive tissues while simultaneously selecting the most appropriate treatment strategy for each individual patient.
Reviewing the Latest Global Evidence
Rather than conducting a clinical trial, the researchers performed a Systematic Literature Review (SLR) following the internationally recognized PRISMA 2020 guidelines.
The team searched five major scientific databases—PubMed, Scopus, ScienceDirect, SpringerLink, and Wiley Online Library.
From 186 published studies, only 32 high-quality articles met all inclusion criteria for detailed analysis. All selected studies were published between 2020 and 2024, ensuring that the review reflects the latest advances in reproductive medicine.
The researchers categorized the findings into four major themes:
- Stem cell therapy for ovarian regeneration.
- Stem cell therapy for endometrial repair.
- Precision reproductive medicine based on biomarkers and genomics.
- Integration of regenerative medicine and personalized fertility treatment.
Stem Cells May Restore Ovarian Function
One of the strongest findings is the potential of stem cell therapy to improve ovarian function in women with infertility caused by Premature Ovarian Insufficiency (POI) and Diminished Ovarian Reserve (DOR).
Across multiple studies, stem cell therapy was shown to:
- stimulate follicle development;
- improve reproductive hormone production;
- reduce ovarian cell damage;
- enhance blood vessel formation in ovarian tissue;
- support recovery of ovarian reserve.
These regenerative effects occur because stem cells release growth factors, cytokines, and extracellular vesicles that promote tissue repair instead of simply replacing damaged cells.
Several clinical studies also reported increased Anti-Müllerian Hormone (AMH) levels and decreased Follicle-Stimulating Hormone (FSH) concentrations after treatment, both of which are important indicators of improved ovarian health.
Repairing the Uterine Environment
The review also found promising evidence that stem cell therapy can repair the endometrium, the inner lining of the uterus where embryo implantation occurs.
Researchers reported that regenerative therapy could:
- increase endometrial thickness;
- improve uterine blood circulation;
- stimulate new blood vessel formation;
- reduce scar tissue and fibrosis;
- enhance endometrial receptivity for embryo implantation.
These improvements are particularly important because successful pregnancy depends not only on embryo quality but also on a healthy uterine environment capable of supporting implantation and fetal development.
Personalized Fertility Care
Another major finding is the growing importance of precision reproductive medicine in modern fertility care.
Instead of applying the same treatment protocol to every patient, this approach integrates:
- reproductive biomarkers;
- hormone profiles;
- ovarian reserve assessment;
- genomic information;
- reproductive history;
- environmental and lifestyle factors.
This personalized strategy allows physicians to predict treatment response more accurately, optimize therapeutic decisions, and reduce unnecessary medical interventions.
The authors note that women with similar infertility diagnoses often respond differently to the same treatment. Precision medicine addresses this challenge by tailoring therapy to each patient's biological characteristics.
A New Direction for Infertility Treatment
Perhaps the most significant conclusion of the review is that the future of infertility management may lie in combining regenerative medicine with precision reproductive medicine.
Stem cell therapy focuses on repairing damaged reproductive tissues, while precision medicine identifies the patients most likely to benefit, determines the optimal timing of treatment, and guides individualized clinical decision-making.
According to Dr. Rimonta Febby Gunanegara and colleagues, this integrated strategy could substantially improve outcomes for women with complex infertility cases that respond poorly to conventional fertility treatments.
The researchers also emphasize that current evidence is still largely based on experimental research and early-stage clinical trials. Larger multicenter studies, standardized treatment protocols, long-term safety evaluations, and broader clinical implementation will be necessary before these therapies become routine medical practice.
Potential Impact on Healthcare
The review provides valuable insights into the future of reproductive medicine.
If ongoing research confirms its effectiveness and safety, integrating stem cell therapy with precision reproductive medicine could:
- improve infertility treatment success rates;
- reduce repeated failures of assisted reproductive technologies;
- enable highly personalized fertility care;
- accelerate the development of regenerative reproductive medicine;
- support evidence-based reproductive health policies.
For developing countries such as Indonesia, these innovations may also contribute to more advanced, patient-centered fertility services that address the biological complexity of infertility rather than focusing solely on conception.
Author Profile
Dr. Rimonta Febby Gunanegara is a researcher and academic at Maranatha Christian University, Bandung, specializing in reproductive health, regenerative medicine, and innovative infertility therapies.
Dr. Hanom Husni Syam is affiliated with Padjadjaran University and Dr. Hasan Sadikin General Hospital, Bandung, with expertise in reproductive medicine and clinical healthcare.
Research Source
Article Title: The Convergence of Stem Cell Therapy and Precision Reproductive Medicine in the Management of Female Infertility
Authors: Rimonta Febby Gunanegara & Hanom Husni Syam
Journal: International Journal of Applied and Scientific Research (IJASR), Vol. 4 No. 4 (2026)
0 Komentar